DHSC publishes proposals to amend pharmacy governance, current legislation on dispensing errors


Share post:

The Department of Health and Social Care (DHSC) has published plans to amend current pharmacy legislation on dispensing errors and clarify how registered pharmacies are governed.

The Department’s response to a public consultation on rebalancing medicines legislation and pharmacy regulation programme first proposed in summer 2018 was delayed due to Brexit and the Covid-19 pandemic.

The programme aims to clarify and strengthen the organizational governance arrangements of registered pharmacies, specifically to define and clarify the core purpose of the Responsible Pharmacist and Superintendent Pharmacist roles.

It will also give the General Pharmaceutical Council (GPhC) powers to define in professional standards how those roles are fulfilled.

These plans are part of a wider commitment from the government to pursue legislative change to make better use of the skill mix in pharmacy teams to deliver more clinical services in the community and support wider NHS capacity.

The orders will now progress through Parliament and, pending approval by both Houses, would need final approval by the Privy Council before they can commence.


Please enter your comment!
Please enter your name here

Current Issue June 2023

Related articles

Shadow Health Minister Preet Kaur Gill visits pharmacy in Staffordshire

Preet Kaur Gill, Shadow Minister for Primary Care and Public Health, has paid a recent visit to a...

Superdrug to halt single-use vape sales in UK, Ireland due to environmental concerns

British pharmacy chain Superdrug has announced plans to cease the sale of disposable vapes in all its UK...

Closure of temporary registers by 31 March 2024: GPhC

Pharmacists on the temporary register will be automatically removed on April 1, unless they have applied to rejoin the...

MHRA grants authorisation for LEO Pharma’s Adtralza 2 mL pen solution

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the marketing authorisation of Adtralza, a dermatological solution...